Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 97 of the 100 references it cites were found in a registry or an index.

Empirical evidence for discrete neurocognitive subgroups in patients with non-psychotic major depressive disorder: clinical implications

Abstract

Background Neuropsychological deficits are present across various cognitive domains in major depressive disorder (MDD). However, a consistent and specific profile of neuropsychological abnormalities has not yet been established. Methods We assessed cognition in 170 patients with non-psychotic MDD using the Brief Assessment of Cognition in Schizophrenia and the scores were compared with those of 42 patients with schizophrenia as a reference for severity of cognitive impairment. Hierarchical cluster analysis was conducted to determine whether there are discrete neurocognitive subgroups in MDD. We then compared the subgroups in terms of several clinical factors and social functioning. Results Three distinct neurocognitive subgroups were found: (1) a mild impairment subgroup with near-normative performance and mild dysfunction in motor speed; (2) a selective impairment subgroup, which exhibited preserved working memory and executive function, but moderate to severe deficits in verbal memory, motor speed, verbal fluency, and attention/information processing speed; and (3) a global impairment subgroup with moderate to severe deficits across all neurocognitive domains, comparable with deficits in schizophrenia. The global impairment subgroup was characterized by lower pre-morbid intelligence quotient (IQ). Moreover, a significant difference between groups was observed in premorbid IQ (p = 0.003), antidepressant dose (p = 0.043), antipsychotic dose (p = 0.013), or anxiolytic dose (p…

Overview

Integrity signals

Registry

Crossref · 10.1017/s003329171800034x

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 100 references

Research works printed but not linked: 3

  1. Kaneda, 2013, Evaluation of cognitive functions in a normal population in Japan using the brief assessment of cognition in schizophrenia Japanese version (BACS-J), Seishinigaku, 55, 167
  2. Goto, 2005, Reliability and validity of the Japanese version of the social adaptation self-evaluation scale (SASS), Clinical Psychiatry, 47, 483
  3. Inagaki, 2006, Dose equivalence of psychotropic drugs: 2006-version, Japanese journal of clinical psychopharmacology, 9, 1443

Cited by

See all 61

Metadata

Authors
Pu, S., Noda, T., Setoyama, S., & Nakagome, K.
Affiliations
National Center of Neurology and Psychiatry (JP)
Corresponding author
Pu, Shenghong
Venue
Psychological Medicine
Published
2018-04-22
Volume
48
Issue
16
Pages
2717-2729
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W2800580232
Cited by
60
References
100
Citations by year
2026: 11 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 8 · 2020: 8 · 2019: 2 · 2018: 1
FWCI
3.07
Type
journal article
Language
en
Open access
closed
Locations
  • Psychological Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (16H03250)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
major depressive disorder, non-psychotic depression, neurocognitive impairment, Brief Assessment of Cognition in Schizophrenia, premorbid intelligence, motor speed, verbal memory, executive function, working memory, attention, social functioning, antidepressant dose, antipsychotic dosing, schizophrenia comparison
MeSH terms
Adult, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Schizophrenia, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Empirical evidence for discrete neurocognitive subgroups in patients with non-psychotic major depressive disorder: clinical implications. https://app.cochat.ai/papers/10.1017/s003329171800034x
The paper
Pu, S., Noda, T., Setoyama, S., & Nakagome, K. (2018). Empirical evidence for discrete neurocognitive subgroups in patients with non-psychotic major depressive disorder: clinical implications. Psychological Medicine. https://doi.org/10.1017/s003329171800034x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.